These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Updates and Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. Hourigan SK; Nicholson MR; Kahn SA; Kellermayer R J Pediatr Gastroenterol Nutr; 2021 Oct; 73(4):430-432. PubMed ID: 34238831 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection. Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405 [TBL] [Abstract][Full Text] [Related]
9. Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease. Cho S; Spencer E; Hirten R; Grinspan A; Dubinsky MC J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):343-347. PubMed ID: 30320666 [TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis. Porcari S; Baunwall SMD; Occhionero AS; Ingrosso MR; Ford AC; Hvas CL; Gasbarrini A; Cammarota G; Ianiro G J Autoimmun; 2023 Dec; 141():103036. PubMed ID: 37098448 [TBL] [Abstract][Full Text] [Related]
11. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection. Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663 [TBL] [Abstract][Full Text] [Related]
12. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection. Mamo Y; Woodworth MH; Wang T; Dhere T; Kraft CS Clin Infect Dis; 2018 May; 66(11):1705-1711. PubMed ID: 29272401 [TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients. Montalto M; Gallo A; Agnitelli MC; Pellegrino S; Lipari A; Pero E; Covino M; Landi F; Gasbarrini A; Cammarota G; Ianiro G J Am Geriatr Soc; 2023 Nov; 71(11):3530-3537. PubMed ID: 37458581 [TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile. Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776 [TBL] [Abstract][Full Text] [Related]
15. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure. Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961 [TBL] [Abstract][Full Text] [Related]
16. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals. Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106 [TBL] [Abstract][Full Text] [Related]